BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5916499)

  • 1. Ring-d-bridged steroid analogs. II. 14-alpha, 17-alpha-etheno-16-alpha-carbomethoxypregn-4-ene-3, 20-dione.
    Solo AJ; Singh B
    J Med Chem; 1966 Mar; 9(2):179-81. PubMed ID: 5916499
    [No Abstract]   [Full Text] [Related]  

  • 2. Ring-D-bridged steroid analogs. V. 14-alpha,17-alpha-etheno-15,16-di(trifluoromethyl)pregna-4,15-diene-3,20-dione and 14-alpha,17-alpha-ethano-15-beta,16-beta-di(trifluoromethyl)pregn-4-ene-3,20-dione.
    Solo AJ; Singh B
    J Med Chem; 1967 Nov; 10(6):1048-51. PubMed ID: 6069771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between chemical structure and gestagenic activity in a new series of pentacyclic analogs of progesterone--pentaranes].
    Akhrem AA; Sotskova IV; Kulikova LE; Terekhina AI; Levina IS
    Dokl Akad Nauk SSSR; 1973 Mar; 209(2):504-7. PubMed ID: 4700396
    [No Abstract]   [Full Text] [Related]  

  • 4. Ring-D-bridged steroid analogs. VI. Proof of stereochemistry and further reactions of 14alpha, 17alpha-etheno-16alpha-carbomethoxypregn-5-ene-3beta-ol-20-one acetate.
    Solo AJ; Singh B; Shefter E; Cooper A
    Steroids; 1968 May; 11(5):637-48. PubMed ID: 5650690
    [No Abstract]   [Full Text] [Related]  

  • 5. Ring-D-bridge steroid analogs. IV. 14alpha, 17alpha-ethenopregn-4-end-3,20-dione.
    Solo AJ; Singh B
    J Med Chem; 1966 Nov; 9(6):957-8. PubMed ID: 5972061
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical and biological properties of some 17-substituted estradiol derivatives.
    Counsell RE; Klimstra PD; Elton RL; Nutting EF
    J Med Chem; 1966 Sep; 9(5):689-92. PubMed ID: 5969040
    [No Abstract]   [Full Text] [Related]  

  • 7. Totally synthetic steroid hormones. XIV. (+-) -18-Methyl-19-norprogesterone, 18-methyl-19-nordesoxycorticosterone and related compounds.
    Hughes GA; Jen TY; Smith H
    Steroids; 1966 Dec; 8(6):947-66. PubMed ID: 5965953
    [No Abstract]   [Full Text] [Related]  

  • 8. Sustained release hormonal preparations. 11. Biological effectiveness of (DL)-13 -ethyl-17 -ethynyl-17 -hydroxy-4-gonen-3-one released from polydimethylsiloxane capsules.
    Zbuzková V; Kincl FA
    Endocrinol Exp; 1970; 4(4):215-20. PubMed ID: 5317371
    [No Abstract]   [Full Text] [Related]  

  • 9. Ring D bridged steroid analogs. 11. The high Clauberg activity of 19-nor-14, 17-ethano-4-pregnene-3,20-dione.
    Solo AJ; Kapoor JN
    J Med Chem; 1973 Mar; 16(3):270-3. PubMed ID: 4733110
    [No Abstract]   [Full Text] [Related]  

  • 10. Block of ovarian compensatory hypertrophy by progestational steroids.
    Jelínek JM; Seda M; Marhan O
    Steroids; 1968 Apr; 11(4):565-70. PubMed ID: 5643152
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral progestational activity of 6-chloro-17-alpha-hydroxy-16-methylenepregna-4,6-diene-3,20-dione acetate.
    Cekan Z; Seda M; Mikulásková J; Syhora K
    Steroids; 1966 Aug; 8(2):205-7. PubMed ID: 5978619
    [No Abstract]   [Full Text] [Related]  

  • 12. On the progestational activity of the 20-ethylene ketals of 21-fluoropregnan-20-ones.
    Löken B; Gut M
    Steroids; 1967 Feb; 9(2):217-27. PubMed ID: 6071815
    [No Abstract]   [Full Text] [Related]  

  • 13. Modified steroid hormones. XLII. Partial synthesis of 17-alpha-acetoxy-6-acetoxymethylpregna 4,6-diene-3,20-dione and its 2-alpha-acetoxy derivative, two acetylated metabolites of megestrol acetate.
    Cooley G; Davies MT; Ellis B; Petrow V
    Tetrahedron; 1966 Jan; 22(1):365-7. PubMed ID: 5927159
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of 6-chloro-16-methylene-17-alpha-- hydroxy-21-fluoro-4,6-pregnadiene-3,20-dione 17-acetate, a potent progestational agent.
    Popper TL; Carlon FE; Shapiro EL; Neri R
    J Med Chem; 1971 Jan; 14(1):33-5. PubMed ID: 5539741
    [No Abstract]   [Full Text] [Related]  

  • 15. Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats.
    Frye CA; Duncan JE
    Brain Res; 1994 Apr; 643(1-2):194-203. PubMed ID: 8032914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utilization of uterine weight as an adjunct to histology in the evaluation of progestational steroids.
    Boris A; DeMartino L
    Steroidologia; 1971; 2(1):57-64. PubMed ID: 5133744
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions of oestradiol and progestins in the mouse uterus.
    Martin L; Finn CA
    J Endocrinol; 1970 Sep; 48(1):109-15. PubMed ID: 5472392
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.
    Bratoeff E; García P; Heuze Y; Soriano J; Mejía A; Labastida AM; Valencia N; Cabeza M
    Steroids; 2010 Jul; 75(7):499-505. PubMed ID: 20359488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compounds related to the steroid hormones. XVII. An improved method of preparation of 21-acetoxy-17-hydroxy-16-beta-methyl-5-alpha-pregn-9-ene-3,20-dione.
    Gregory GI; Hunt JS; May PJ; Nice FA; Phillipps GH
    J Chem Soc Perkin 1; 1966; 23():2201-10. PubMed ID: 5951100
    [No Abstract]   [Full Text] [Related]  

  • 20. Infusion of progestins into the hypothalamus of female New Zealand white rabbits: effect on in vivo luteinizing hormone-releasing hormone release as determined with push-pull perfusion.
    Lin WW; Ramirez VD
    Endocrinology; 1990 Jan; 126(1):261-72. PubMed ID: 2403518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.